Page 478 - Read Online

Du et al. TLRs in cancer

Financial support and sponsorship receptor 3. Nature 2001;413:732-8.
This work was supported in part by NIH Grant 17. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X,
CA176698 and the Texas A&M Health Science Center. Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-
Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/
HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science
Conflicts of interest 1998;282:2085-8.
There are no conflicts of interest. 18. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR,
Eng JK, Akira S, Underhill DM, Aderem A. The innate immune
Patient consent response to bacterial flagellin is mediated by Toll-like receptor 5.
There is no patient involved. Nature 2001;410:1099-103.
19. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S,
Ethics approval Lipford G, Wagner H, Bauer S. Species-specific recognition of single-
stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-9.
This article does not contain any studies with human 20. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting
participants or animals. of innate immunity with Toll-like receptor agonists and antagonists.
Nat Med 2007;13:552-9.
REFERENCES 21. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C,
Flavell RA, Ghosh S. A toll-like receptor that prevents infection by
1. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a uropathogenic bacteria. Science 2004;303:1522-6.
nonclonal system of recognition. Cell 1997;91:295-8. 22. O’Neill LA, Bowie AG. The family of five: TIR-domain-containing
2. Beutler B. Toll-like receptors: how they work and what they do. Curr adaptors in Toll-like receptor signalling. Nat Rev Immunol
Opin Hematol 2002;9:2-10. 2007;7:353-64.
3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate 23. Curtin JF, Liu N, Candolfi M, Xiong W, Assi H, Yagiz K, Edwards
immunity. Cell 2006;124:783-801. MR, Michelsen KS, Kroeger KM, Liu C, Muhammad AK, Clark MC,
4. Pandey S, Kawai T, Akira S. Microbial sensing by Toll-like receptors Arditi M, Comin-Anduix B, Ribas A, Lowenstein PR, Castro MG.
and intracellular nucleic acid sensors. Cold Spring Harb Perspect Biol HMGB1 mediates endogenous TLR2 activation and brain tumor
2015;7:a016246. regression. PLoS Med 2009;6:e10.
5. Schenten D, Nish SA, Yu S, Yan X, Lee HK, Brodsky I, Pasman 24. Ribeiro RA, Wanderley CW, Wong DV, Mota JM, Leite CA, Souza
L, Yordy B, Wunderlich FT, Bruning JC, Zhao H, Medzhitov R. MH, Cunha FQ, Lima-Junior RC. Irinotecan- and 5-fluorouracil-
Signaling through the adaptor molecule MyD88 in CD4+ T cells is induced intestinal mucositis: insights into pathogenesis and therapeutic
required to overcome suppression by regulatory T cells. Immunity perspectives. Cancer Chemother Pharmacol 2016;78:881-93.
2014;40:78-90. 25. Kuo WT, Lee TC, Yu LC. Eritoran suppresses colon cancer by altering
6. Wang Y, Su L, Morin MD, Jones BT, Whitby LR, Surakattula MM, a functional balance in Toll-like receptors that bind lipopolysaccharide.
Huang H, Shi H, Choi JH, Wang KW, Moresco EM, Berger M, Zhan Cancer Res 2016;76:4684-95.
X, Zhang H, Boger DL, Beutler B. TLR4/MD-2 activation by a 26. Prakash H, Nadella V, Singh S, Schmitz-Winnenthal H. CD14/
synthetic agonist with no similarity to LPS. Proc Natl Acad Sci U S A TLR4 priming potentially recalibrates and exerts anti-tumor efficacy
2016;113:E884-93. in tumor associated macrophages in a mouse model of pancreatic
7. Kassiotis G, Stoye JP. Immune responses to endogenous retroelements: carcinoma. Sci Rep 2016;6:31490.
taking the bad with the good. Nat Rev Immunol 2016;16:207-19. 27. Llitjos JF, Auffray C, Alby-Laurent F, Rousseau C, Merdji H, Bonilla
8. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr N, Toubiana J, Belaidouni N, Mira JP, Lucas B, Chiche JD, Pene F.
Opin Immunol 2005;17:338-44. Sepsis-induced expansion of granulocytic myeloid-derived suppressor
9. Maglione PJ, Simchoni N, Cunningham-Rundles C. Toll-like cells promotes tumour growth through Toll-like receptor 4. J Pathol
receptor signaling in primary immune deficiencies. Ann N Y Acad Sci 2016;239:473-83.
2015;1356:1-21. 28. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy
10. O’Neill LA. Glycolytic reprogramming by TLRs in dendritic cells. S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper
Nat Immunol 2014;15:314-5. HS, Itzkowitz SH, Abreu MT. Toll-like receptor-4 promotes the
11. Santoni M, Andrikou K, Sotte V, Bittoni A, Lanese A, Pellei C, Piva development of colitis-associated colorectal tumors. Gastroenterology
F, Conti A, Nabissi M, Santoni G, Cascinu S. Toll like receptors and 2007;133:1869-81.
pancreatic diseases: from a pathogenetic mechanism to a therapeutic 29. Furrie E, Macfarlane S, Thomson G, Macfarlane GT; Microbiology
target. Cancer Treat Rev 2015;41:569-76. & Gut Biology Group; Tayside Tissue & Tumour Bank. Toll-
12. Kawai T, Akira S. The role of pattern-recognition receptors in innate like receptors-2, -3 and -4 expression patterns on human colon
immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-84. and their regulation by mucosal-associated bacteria. Immunology
13. Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate 2005;115:565-74.
immune system. Nat Immunol 2015;16:343-53. 30. Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N,
14. Shah M, Anwar MA, Kim JH, Choi S. Advances in antiviral Mounajjed T, Drew AF. Toll-like receptor expression in normal ovary
therapies targeting Toll-like receptors. Expert Opin Investig Drugs and ovarian tumors. Cancer Immunol Immunother 2009;58:1375-85.
2016;25:437-53. 31. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S,
15. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Visintin I, Rutherford T, Mor G. TLR-4 signaling promotes tumor
Takeda K, Akira S. Differential roles of TLR2 and TLR4 in recognition growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res
of gram-negative and gram-positive bacterial cell wall components. 2006;66:3859-68.
Immunity 1999;11:443-51. 32. Niedzielska I, Niedzielski Z, Tkacz M, Orawczyk T, Ziaja K,
16. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition Starzewski J, Mazurek U, Markowski J. Toll-like receptors and the
of double-stranded RNA and activation of NF-kappaB by Toll-like tendency of normal mucous membrane to transform to polyp or
468 Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ December 29, 2016